Custom Synthesis, from Idea to Market

Our Business

R&D to Commercial Production

Business

Business

Overview

Who we are

  • Established in the year 1995, among the first in India to focus on providing high-end contract research and manufacturing of advanced intermediates and APIs covering oncology and other therapeutic areas

Our relationships

  • Partnered with various innovators to develop advanced intermediates and supply at a commercial scale post-launch
Overview

Our capabilities

  • Synthesis of a wide range of diverse chemical entities.
  • Only company in the world to develop and successfully commercialize a synthetic process for Irinotecan.

Our assets

  • State-of-the-art manufacturing facilities spread over 30 acres with a total reactor volume over 165,000 liters, located in Hyderabad (USFDA approved) and Vizag.

Our History

Rama RaoFounded by

Dr. A. V. Rama Rao

  •  Former Director of the Indian Institute of Chemical Technology
  •  Trained 109 PhD students and published 262 papers.
  •  Developed over 50 drug technologies that have been commercialized by the pharmaceutical industry.
The President of India bestowed Rama Rao with the ‘Padma Shri’ in 1991 and the ‘Padma Bhushan’ in 2016 for extraordinary contributions to science and industry.
Avralab Logo
In 1980, Rama Rao discovered a novel and efficient process to isolate Vinblastine and Vincristine from the Vinca Rosea. This outstanding breakthrough offered a new perspective to industry oriented research and inspired the next generation of scientists to ceaselessly push for innovation.
The emblematic use of Vinca Rosea petals on the Avra logo represents this landmark achievement.

Timeline of Key Events

Timeline of Key Events

Avralab Logo

www.avralab.com

Links

Home
Privacy Policy
Terms & Conditions